GL1X · GenesisL1 explorer

MolNFT v1 · #116954 · protein

Crystal structure of DOT1L in complex with inhibitor CPD3 [(2,6- DICHLOROPHENYL)(QUINOLIN-6-YL)METHANONE]

5DTQ · Histone-lysine N-methyltransferase, H3 lysine-79 specific: “Crystal structure of DOT1L in complex with inhibitor CPD3 [(2,6- DICHLOROPHENYL)(QUINOLIN-6-YL)METHANONE]”. X-ray diffraction, 1 ligand (5F6), 3 pockets (best druggability…

PDB
5DTQ
Type
protein
Length
639 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase, H3 lysine-79 specific
EC
2.1.1.43
UniProt
Q8TEK3
Ligands
5F6
Pockets
3 · best druggability 0.88

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43)protein32045% helix, 15% strandQ8TEK3
BHistone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43)protein31945% helix, 15% strandQ8TEK3

Ligands and binding sites

  • 5F6 · (2,6-dichlorophenyl)(quinolin-6-yl)methanone · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111220.880.901425F6
2900.470.8117empty
3620.300.7416empty

Interfaces

1 interface between chains.

  • A–B · 1607 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 5DTQ · Crystal structure of Dot1L in complex with inhibitor CPD3… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8TEK3 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase, H3 lysine-79… · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.